“Dysregulated circulating miR-4429 serves as a novel non-invasive biomarker and is correlated with EGFR mutation in patients with non-small cell lung cancer” (2022) Biomolecules and Biomedicine, 22(4), pp. 553–559. doi:10.17305/bjbms.2021.6450.